Adverse events240

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 240

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Alanine aminotransferase increased	Investigations	Tafasitamab Dose Level 1 + 25 mg Lenalidomide	1	6	2
other	Alanine aminotransferase increased	Investigations	Tafasitamab Dose Level 2 + 25 mg Lenalidomide	2	47	2
other	Alanine aminotransferase increased	Investigations	Total	3	53	4
other	Anaemia	Blood and lymphatic system disorders	Tafasitamab Dose Level 1 + 25 mg Lenalidomide	2	6	4
other	Anaemia	Blood and lymphatic system disorders	Tafasitamab Dose Level 2 + 25 mg Lenalidomide	9	47	12
other	Anaemia	Blood and lymphatic system disorders	Total	11	53	16
other	Anxiety	Psychiatric disorders	Tafasitamab Dose Level 1 + 25 mg Lenalidomide	1	6	1
other	Anxiety	Psychiatric disorders	Tafasitamab Dose Level 2 + 25 mg Lenalidomide	1	47	1
other	Anxiety	Psychiatric disorders	Total	2	53	2
other	Arthralgia	Musculoskeletal and connective tissue disorders	Tafasitamab Dose Level 1 + 25 mg Lenalidomide	0	6	0
other	Arthralgia	Musculoskeletal and connective tissue disorders	Tafasitamab Dose Level 2 + 25 mg Lenalidomide	3	47	3
other	Arthralgia	Musculoskeletal and connective tissue disorders	Total	3	53	3
other	Aspartate aminotransferase increased	Investigations	Tafasitamab Dose Level 1 + 25 mg Lenalidomide	1	6	1
other	Aspartate aminotransferase increased	Investigations	Tafasitamab Dose Level 2 + 25 mg Lenalidomide	2	47	2
other	Aspartate aminotransferase increased	Investigations	Total	3	53	3
other	Asthenia	General disorders	Tafasitamab Dose Level 1 + 25 mg Lenalidomide	1	6	1
other	Asthenia	General disorders	Tafasitamab Dose Level 2 + 25 mg Lenalidomide	6	47	7
other	Asthenia	General disorders	Total	7	53	8
other	Atrial flutter	Cardiac disorders	Tafasitamab Dose Level 1 + 25 mg Lenalidomide	1	6	1
other	Atrial flutter	Cardiac disorders	Tafasitamab Dose Level 2 + 25 mg Lenalidomide	0	47	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05222555/events

API reference For AI assistants

Adverse events240

Sources 3

Read this list from software.